Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Schedule of preliminary purchase consideration (Details)

v3.22.2.2
ACQUISITIONS - Schedule of preliminary purchase consideration (Details) - Kind Therapeutics USA LLC.
$ in Thousands
1 Months Ended
Apr. 30, 2022
USD ($)
Cash consideration:  
Cash paid at closing $ 10,128
Release of escrow 2,444
Severance paid from escrow 556
Less cash acquired (2,310)
Net cash consideration 10,818
Note payable 5,634
Write-off accounts receivable 658
Write-off of deferred accounts receivable 842
Total fair value of consideration transferred $ 17,952